The emergence and evolution of pathogenic Escherichia coli strains associated with animal and human infections continues being a topic of active investigation in recent years. Latin America has responded to this thread establishing the Latin American Coalition for Escherichia coli Research (LACER), a multidisciplinary group of scientists applying principles of the One Health initiative. LACER is integrating animal, human and environmental health for the mutual benefit of all, while reducing the impact of human disease. Here, I depict the usefulness of this approach by providing three examples from several priority areas in E. coli research and comparing them to the activities performed by LACER, which are enhancing collaborative efforts in biomedical research and providing a translational platform to connect with epidemiological studies and public health policy makers. The manuscript concludes with a brief historical description regarding the establishment of LACER, emphasizing the importance of collaboration between health professionals of different international organizations and not only across one specific country, to effectively combat current and future E. coli infections. The benefits of utilizing 'One Health' concepts in the establishment of LACER should encourage other professionals studying zoonotic or environmentally acquired human infections to implement effective international collaborations to combat common problems.
INTRODUCTION
It is well documented that pathogenic forms of Escherichia coli, which are associated with human and animal diseases, are remarkably diverse. Certain pathogenic isolates cause enteric diseases ranging in symptoms from watery diarrhea to severe hemorrhagic colitis, while other E. coli stains may cause extra-intestinal infections, including those pathologies associated with the urinary tract or systemic problems, such as septicemia and meningitis (Kaper, Nataro and Mobley 2004; Torres 2010 Torres , 2016a . The better studied extracellular pathogenic E. coli strains are mainly clustered in three major groups (pathotypes or pathovars): uropathogenic E. coli, neonatal meningitis E. coli and avian pathogenic E. coli, while the isolates associated with diarrheal disease are more diverse, clustered as diarrheagenic E. coli isolates, and at least six pathovars of E. coli have been recognized (Kaper, Nataro and Mobley 2004; Arenas-Hernández, Martínez-Laguna and Torres 2012) . The diarrheagenic pathovars are known as enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC), enterotoxigenic E. coli (ETEC), enteroaggregative E. coli (EAEC), enteroinvasive E. coli (EIEC) and diffusely adherent E. coli (DAEC) (Fig. 1) .
The diversity of the E. coli pathovars is linked to the expression of specific virulence factors, resulting in distinct clinical manifestations. EPEC strains are important diarrheal pathogens of young children and produced a characteristic intestinal ETEC, enterotoxigenic E. coli; EAEC, enteroaggregative E. coli; EPEC, enteropathogenic E. coli; aEPEC, atypical EPEC; tEPEC, typical EPEC; EHEC, enterohemorrhagic E. coli; EIEC, enteroinvasive E. coli; DAEC, diffusely adherent E. coli. lesion known as the attaching and effacing (A/E), which is associated with the presence of the locus of enterocyte effacement pathogenicity island (Kaper, Nataro and Mobley 2004; Hu and Torres 2015; Gaytán 2016) . The EPEC pathogroup is further divided into typical EPEC (tEPEC) strains, which also produce a type IV pilus, known as the bundle-forming pilus, and encoded in the virulence-associated plasmid pEAF. Those EPEC strains that lack the pEAF plasmid are known as atypical EPEC (aEPEC) (Gomes et al. 2016; Scaletsky and Fagundes-Neto 2016) .
Likewise, EHEC strains are characterized for their ability to produce the A/E lesion; however, this pathovar is also distinguished for its ability to produce Shiga toxins (Stx) and all strains in this group, regardless of their capacity to cause disease in humans, are included in the Shiga toxin-producing E. coli category (Kaper, Nataro and Mobley 2004; Rivas, Chinen and Guth 2016) . In addition to cause diarrhea, EHEC strains can produce bloody diarrhea (hemorrhagic colitis) and a small proportion of patients (particularly young children and the elderly) developed a more serious clinical complication known as the hemolytic uremic syndrome (Arenas-Hernández, Martínez-Laguna and Torres 2012).
In the case of ETEC, these strains can cause severe diarrhea, and the disease is life threatening due to significant fluid loss and severe dehydration. ETEC strains attach to the epithelia of the small intestine using a wide variety of adhesins, commonly known as colonization factors (Del Canto and Torres 2014) . Furthermore, ETEC secretes either of both of two varieties of enterotoxins, the heat-labile enterotoxin (LT) and heat-stable enterotoxin (ST), and also evades host defenses while causing damage to the host (Kaper, Nataro and Mobley 2004; ArenasHernández, Martínez-Laguna and Torres 2012) .
EAEC is another pathovar which is very heterogeneous, and the strains are often recovered from apparently healthy individuals. However, EAEC are increasingly recognized cause of diarrhea in children in developing countries, with an association to persistent diarrhea (more than 14 days), illness and death (Kaper, Nataro and Mobley 2004; Elias and Navarro-Garcia 2016) . The primary virulence factor of EAEC associated with biofilm formation is the aggregative adherent fimbria; however, several enterotoxins are linked to diarrheal symptoms, such as the enteroaggregative heat-stable toxin EAST-1, the cytotoxin Pet and an anti-aggregation protein known as dispersin (Elias and Navarro-Garcia 2016) .
EIEC is an E. coli pathovar whose infection causes a syndrome that is identical to shigellosis, with profuse diarrhea and high fever (Kaper, Nataro and Mobley 2004) . EIEC isolates are highly invasive and they possess a large virulence plasmid that encodes determinants mediating the invasive phenotype as well as components of a type III secretion (T3S) apparatus. EIEC produce no bona fide toxins, but T3S effectors participate in the damage of the intestinal epithelia and resulting in cell destruction. Finally, DAEC is a very pleiotropic pathovar and its relation to acute diarrhea is a topic that has slowly gained public health significance (Meza-Segura and Estrada-Garcia 2016). There is a limited number of studies regarding the virulence and pathogenic mechanisms of DAEC but it is evident that the virulence factor(s) in DAEC are implicated in diffuse attachment to the intestinal lining of the infected host, resulting in diarrheal disease.
Most E. coli diarrhea cases are caused by ETEC (233 million; 95% UI 154-380 million) worldwide; however, other pathovars also cause significant disease, such as EPEC and, increasingly, EAEC (Pires et al. 2015) . Both EHEC and other STEC infections are relatively rare in both developed and developing countries; however, the serotype O157:H7 is considered an important pathogen due to the potential for life-threatening sequelae. In Latin America, the distribution of E. coli pathovars is highly regionalized and the impact of diarrheal disease is quite distinct from country to country (Torres 2010) . Epidemiological studies in Mexico (Navarro and Estrada-Garcia 2010) , Brazil (Guth, Picheth and Gomes 2010) , Argentina (Rivas et al. 2010) , Chile (Vidal et al. 2010) , Venezuela (Hannaoui et al. 2010) , Nicaragua (Reyes et al. 2009 ), Paraguay (Canata et al. 2016) , Uruguay, Colombia and Peru (Varela, Gomez-Duarte and Ochoa 2010) have elucidated a quite unique map for the distribution of E. coli pathovars, confirming the regional prevalence of different pathogenic E. coli isolates (Fig. 1) . For example, most reported diarrheal cases in Mexico, Colombia and Nicaragua are associated with ETEC infections. In contrast, the most prevalent diarrheal pathovar in Brazil, Paraguay and Peru corresponded to EAEC, while EPEC (aEPEC or tEPEC) is prevalent in Venezuela, Chile, Argentina and Uruguay. Several other pathovars required specific attention and, for example, in the case of EHEC, particularly the serotype O157:H7, this pathovar has regional impact in the south part of the continent and it is depicted by the predominance of O157 Argentinean serotype lineages associated with prevalence and severity of the disease (Mellor et al. 2015) .
The distribution of pathogenic E. coli across different populations and the diversity of the pathovars that display regional variability results in a complex scenario for a continent where globalization of the food industry and its impact on agricultural trades as well as travel interconnectivity have facilitated global disease spread. This complexity of the problem that impacts animal and human health as well as food and animal production and distribution also contains common aspects that can be addressed using the concepts summarized by the 'One Health' initiative. One Health is applicable to understand E. coli diarrheal disease because it recognizes the relationship between health and disease at the human, animal and environment interfaces and has become an important focus in both medical and veterinary sciences. Furthermore, this initiative recommends the use of treatment(s) to combat the pathogen and promotes a systemic change in the management of the risk.
This manuscript will focus first in presenting three examples of the diversity and clonal distribution of pathogenic E. coli, with a particular focus in Latin America. The first two examples correspond to the emergence of novel regional isolates that are having an impact in human disease. The third example presents the clonal distribution of clinical pathogenic E. coli isolates across populations in the current era of widespread antibiotic resistance. Finally, the paper describes the Latin American E. coli researchers' efforts to utilize the One Health initiative and unify the regional efforts to find common solutions through the creation of the Latin American Coalition for Escherichia coli Research (LACER).
EHEC O157:H7 AND THE EMERGENCE OF HYBRID STRAINS
Since its first description in the early 1990s, EHEC serotype O157:H7 has remained as an important cause of food-acquired infections worldwide. In the USA, the number of cases associated with food outbreaks remains a health concern; however, in recent years (2014) (2015) , the incidence of laboratoryconfirmed EHEC O157 infections was significantly lower than previous years (2006) (2007) (2008) ; this is attributed to several factors associated with food safety (Crim et al. 2015) . Similar situations have been reported in developed countries around the globe and, although difficult to estimate, the annual incidence of EHECassociated hemolytic uremic syndrome (HUS) continuous to be reported as 2-3 per 100 000 cases in all age groups (Noris and Remuzzi 2009 ). In contrast, EHEC non-O157 infections have been increasingly reported worldwide and this is, in part, to an increase in the number of laboratories testing for Shiga toxin and, consequently, increased recognition of EHEC non-O157 infections (Gould et al. 2013; Kanayama et al. 2015) . The emergence and/or accurate detection of EHEC non-O157 isolates becomes of significant concern when large outbreaks occur and the etiological agent results to be a new Escherichia coli serotype (NavarroGarcia 2014) . For example, in 2011, a large outbreak caused by a new E. coli serotype O104:H4 was reported in Europe, which involved 4075 cases (including 908 cases complicated by HUS) and 50 deaths in 16 countries (CDC 2013) . Further analysis of this isolate demonstrated that this outbreak strain carries genes characteristic of both EHEC (Shiga toxin genes) and EAEC. The impact of these new EHEC/EAEC hybrid strains in human disease is an area of active investigation, particularly because the combination of virulence genes resulting in a strain with high pathogenicity potential could result in the next large worldwide outbreak.
In South America, particularly Argentina, EHEC O157:H7 remains as an important food-borne pathogen of significant human concern because it is the dominant serotype in HUS cases. The incidence of HUS in Argentina has been reported to be as high as 12.2 cases per 100 000 children younger than 5 years of age (Rivas et al. 2006) . Furthermore, HUS is the leading cause of acute renal failure among children and is responsible for ∼20% of kidney transplants among children and adolescents in this country (Rivas et al. 2008) . Although several risk factors for EHEC infections in Argentina have been identified, including eating undercooked beef and contact with a child <5 years of age with diarrhea (Rivas et al. 2008) , the high incidence of EHEC O157 infections and HUS cases in this country is considered a public health concern because the possibility exists that this pathogen could be exported to other countries. In fact, in some areas of Argentina, it has been reported the presence almost exclusively of E. coli O157 strains belonging to the hypervirulent clade 8, displaying homogeneity in EHEC O157 genotypes which are detected in human and bovine isolates, and representing a significant human risk factor (Pianciola et al. 2016) . Because of the impact of this human disease in Argentinian public health, in 2000, HUS became a reportable disease; in 2013, the national day celebrating the fight against HUS was approved as law in this country (http://www.legisalud.gov.ar/atlas/categorias/suh.html).
With respect to hybrid strains, efforts to identify these types of isolates in Latin America were enhanced after the appearance of the European outbreak EHEC/EAEC O104:H4 strain. Prospective studies identified a child admitted into a hospital in Argentina and suffering from acute diarrhea. Escherichia coli was isolated from the stool sample and characterize at the National Reference Laboratory. The results indicated that an EAEC of serotype O104:H4 was the cause of the infection; although virulence factors linked to EAEC were identified, the isolate was negative for the Shiga toxin genes (Carbonari et al. 2014) . The identification of this EAEC O104:H4 strain causing human infection has reinforced the need to implement better detection methods for all E. coli pathovars in Latin America (Rivas, Chinen and Guth 2016) .
EMERGENCE OF ATYPICAL EPEC STRAINS AND THE ANIMAL RESERVOIR
It has been known for a long time that humans are the major reservoir of EPEC (mainly tEPEC) and other pathovars (EAEC and ETEC), while cattle are the main reservoir for EHEC and other STEC strains. In contrast to EAEC and ETEC strains, which have been isolated from various animals, tEPEC strains are rarely isolated from animals. Furthermore, information about aEPEC is more scarce, even though it has been confirmed that the prevalence of aEPEC is higher than tEPEC in several countries (Hu and Torres 2015; Gomes et al. 2016) , including those located in the Latin American region (Fig. 1) .
A question that has remained elusive and without a satisfying answer is the role of animals in the transmission of aEPEC and as a potential source of human infections. It has been demonstrated that aEPEC isolates are present in both healthy and sick animals (dog, monkey, cats and bovines) and some aEPEC strains are known to play a pathogenic role in cats and other animals (Morato et al. 2009; Moura et al. 2009 ). Furthermore, some studies have associated pets as well as farm and wild animals as reservoirs of aEPEC and as an infection source for humans (Hernandes et al. 2009 ); however, the data demonstrating that aEPEC strains isolated from animals represent risks for human health is missing.
Therefore, several studies have evaluated whether animals are carriers of aEPEC strains associated with human infections (Gomes et al. 2016) . Such studies have found the presence of potentially human pathogenic EPEC types in domesticated and wild animals, which indicates that transmission between animals and humans can occur. However, the possibility also exist that some animals, mainly pets, acquired aEPEC strains through contact with human feces (Moura et al. 2009 ). Because humans can also act as an aEPEC reservoir, the possibility exists that the cycle of infection between animals and humans cannot be disregarded since transmission dynamics are not fully understood.
Recent studies from Brazil (Martins et al. 2016) , Argentina (Alonso et al. 2016) and Ecuador (Vasco, Graham and Trueba 2016) investigated the presence of aEPEC in lambs, chickens and domestic animals (pigs, dogs and chickens), respectively. The study from Ecuador confirmed the presence of aEPEC in domestic animals and showed that this pathovar was prevalent (10.5%) in children and animals. More importantly, this study provided evidence indicating that active transmission of aEPEC occurred between domestic animals and humans (Vasco, Graham and Trueba 2016) . In the case of the Argentinian study, the investigators isolated aEPEC strains representing a wide variety of serotypes; however, some of them have been reported in other animal species and in children with diarrhea (Alonso et al. 2016) . These findings suggested that chicken and chicken products might be important sources of aEPEC strains and highlighted the need to improve hygiene practices in those handling such products. Finally, the Brazilian study isolated for the first time aEPEC from lambs raised for meat in the southern part of this country. The findings indicated that from 11 serotypes identified, 8 have been described among human aEPEC strains (Martins et al. 2016) , which suggest that this source of meat might also contribute to the dissemination of this pathogen to humans.
ANTIBIOTIC RESISTANCE IN PATHOGENIC ESCHERICHIA COLI STRAINS
An urgent threat to human health that requires more monitoring and prevention activities includes the emergence of resistant bacteria which is occurring worldwide, endangering the efficacy of antibiotics (Berezin and Solórzano 2014; Ochoa and Gómez-Duarte 2016) . The antibiotic resistance emergency has been attributed to the overuse and misuse of these medications, as well as a lack of new drug development. The emergence, propagation, accumulation and maintenance of strains of antimicrobial-resistant bacteria, including E. coli, have become a worldwide health concern in human and veterinary medicine (Ochoa and Gómez-Duarte 2016) . In Latin America, the Pan American Health Organization, WHO's Regional Office for the Americas, coordinates the collection of data on antibiotic resistance and their results (up to 2014) have identified high levels of E. coli resistance to third generation cephalosporins and fluoroquinolones, the two commonly used types of antibiotics in the Americas (http://www. who.int/mediacentre/news/releases/2014/amr-report/en/).
Another study associated with the SENTRY Antimicrobial Surveillance Program has evaluated the frequency and resistance rates of Gram-negative bacilli isolated from Latin American medical centers located in Argentina, Brazil, Chile and Mexico (Gales et al. 2012) . For example, all Gram-negative organisms isolated and displaying a reduced susceptibility to imipenem or meropenem (MIC ≥ 2 μg/mL) were screened for carbapenemase production and in the case of E. coli, the Extended-Spectrum β-Lactamases (ESBL) rates were estimated to be 18.1%, 12.8%, 23.8% and 48.4% for Argentina, Brazil, Chile and Mexico, respectively. Interestingly, resistance to colistin, one of the last resort antibiotics for multidrug-resistant bacteria, was no detected in 99.8% of E. coli isolates evaluated in this study (Gales et al. 2012) .
This previous finding was promising because E. coli strains resistant to the last line of antibiotic defense were not identified; however, emergence of plasmid-mediated colistin resistance in Asia, particularly in China, resulted in an increased concern around the world (Liu et al. 2016) . Interestingly, the mcr-1 gene was originally detected in commensal E. coli isolates from pigs, but immediately associated with other Enterobacteriaceae species from farm animals, and from human origin. Because a small study of short-term intestinal colonization from individuals travelling to South America suggested the presence of mcr-1 gene in the Latin American region (Rapoport et al. 2016) , a more comprehensive analysis needed to be performed.
In such study, a collection of colistin-resistant clinical isolates submitted to the Argentinian National Reference Laboratory in Antimicrobial Resistance in a period of 8 years until 2016 was evaluated for the presence of the mcr-1 gene (Rapoport et al. 2016) . From a total of 28 E. coli strains analyzed, the mcr-1 gene was detected in nine isolates recovered from patients admitted to six hospitals from three cities. As stated by the authors, the study represented the first confirmed mcr-1-positive clinical isolates from Latin American and validating the global distribution of this resistant mechanism. More alarming is the fact that the Argentinian mcr-1 positive E. coli isolates were associated with invasive infections, which suggest the potential fitness of these pathogens to the hospital environment (Rapoport et al. 2016) . Similar to this study, the SENTRY Antimicrobial Surveillance Program evaluated a large collection of worldwide mcr-1-positive E. coli clinical isolates, including some of Latin America, and confirmed the presence of this resistant bacteria in Brazil (Castanheira et al. 2016) . Overall, these studies support the importance of active surveillance of emerging resistant isolates in different regions of the world.
THE CREATION OF THE LACER GROUP
The three examples described before as well as other areas of significant concern related to the complex infectious interplay between Escherichia coli and the host clearly support the need of a large community of specialists with different expertise (veterinarians, physicians, public health officials, bacteriologists, vaccinologists, epidemiologists, etc.) to tackle a variety of E. coli issues affecting the Latin American region. The lack of vaccines to combat these pathogens and the increased risk of acquiring such infections due to the consumption of contaminated food products that are distributed globally and that can potentially spread rapidly across different countries required the attention of a coordinated team of experts. Therefore, it was evident that a regional response of the scientific community to identify, diagnose and defeat the pathogenic E. coli responsible for the different diseases was required (da Silveira and Torres 2010).
During the XXV Brazilian Congress of Microbiology, a group of E. coli researchers from Brazil, Argentina, Mexico and the United States had an informal meeting to discuss future actions to promote and increase scientific collaboration among laboratories, enhance scientific excellence and to develop opportunities to train the next generation of Latin American investigators. As result of this meeting, the LACER was created in 2009, with an initial roster of researchers dedicated to promote and study E. coli research in the region. The coalition was initially established as a multidisciplinary group of 40 E. coli research groups (currently the network includes 70 laboratories) distributed in different countries of Latin America, the United States and Canada, and working in different aspects of E. coli research (da Silveira and Torres 2010; Torres 2017).
The objective of the LACER group from the beginning has always been aligned with the central goal of the One Health initiative, which is dedicated to improve the health of humans and animals, integrating human medicine, veterinary medicine and environmental science. The LACER group utilized a holistic approach to understand E. coli disease and to find different therapeutic approaches for treatment and prevention, involving experts in a wide variety of scientific disciplines. Furthermore, LACER is committed to the dissemination of scientific knowledge within the region, because it is essential to increase collaborations and to promote the interest of young investigators. Therefore, in 2009 the first LACER symposium was held at the State University of Campinas, Brazil, to exchange different research ideas and projects from investigators of the Latin American region ( Fig. 2 ; I LACER). Since then, LACER has hosted four more symposia as part of the Latin American Congress of Microbiology ( Fig. 2 ; II-V LACER). In addition, several workshops, courses and presentations have been organized in international, national and regional meetings.
LACER is a non-profit group with a simplified leadership team in which the members are consulted and participate in the process of deciding which activities will be executed (Torres 2017) . Since its establishment, the investigators made a commitment to share resources and promote education of the trainees, as Figure 2 . A publication summary from the PubMed search engine based on numbers returned using the search term 'diarrhea', 'pathogenic' and 'Escherichia coli'. Furthermore, the five LACER symposia are depicted in the years that were hosted. The publication data from 2016 is partial and truncation represented as a double black bar sign.
well as published their findings in the form or peer-review publications, review articles, posters and books (so far, LACER has published two books: 'Pathogenic Escherichia coli in Latin America' (Torres 2010) and 'Escherichia coli in the Americas' (Torres 2016a) .
ONE HEALTH APPROACH TO ESCHERICHIA COLI RESEARCH IN LATIN AMERICA
As summarized above, The LACER initiative has focused in One Health-related efforts to combat E. coli infections. For example, members have established joined educational efforts between physicians and veterinarians, together with public health officials to prevent and treat E. coli O157:H7 infections caused by the consumption of contaminated meat products and resulting in the high prevalence of HUS cases. This endemic problem in the south of the continent requires the intervention of basic researchers, policy makers, physicians, veterinarians and other health professionals working together to diagnose the infections, find treatments and develop viable vaccines.
Second, LACER members are working to generate joint communications in journals, conferences and social media (LACER has its own Facebook page). An example of this collaborative effort is evident in the increase of peer-review publications within the region. Figure 2 shows PubMed results generated while searching Latin American countries only and the words 'diarrhea', 'pathogenic' and 'Escherichia coli'. The results indicate that a significant increase in the number of publications has occurred since the inception of LACER in 2009, reaching a maximum in 2013 and 2015. Most importantly, ∼15% of those publications in recent years correspond to collaborations between LACER members.
A third area of intense interest has to do with effort to establish a better cross-species disease surveillance and control efforts in public health. As depicted in the example listed above, research efforts are directed to identify the reservoir of aEPEC isolates and whether domestic or wild animals are the source of human infections. Similarly, joint efforts have been established to better understand cross-species E. coli disease transmission within animal species or as zoonotic infections.
Finally, LACER members have established collaborative efforts in the development and evaluation of new diagnostic methods, experimental therapeutic approaches and vaccines for the prevention and control of E. coli infections across species. The most notable are development of an EHEC (STEC) vaccine for cattle and humans and a vaccine against ETEC. In the case of the later, ETEC infections remain as an important cause of death in infants less than 5 years of age. Although decline in the number of infections have been observed worldwide, children still die from ETEC infections that are entirely preventable or treatable. Prevention efforts that focus on ETEC vaccines have become a priority for the Gates Foundation, which has a program to significantly reduce both children suffering and death from this and other enteric diseases (http://www.gatesfoundation.org/What-We-Do/Global-Health/ Enteric-and-Diarrheal-Diseases); although funding is still not specifically targeted for Latin America, the investigators are making significant progress in prevention and treatment.
CONCLUSION
Escherichia coli infections remain a major global public health issue to which the One Health principles represents a promising approach, and therefore LACER goals are aligned with this initiative. The effectiveness of the One Health approach in LACER activities is reflected in the increase of literature (peer-review articles, book chapters, books, communications) in different aspects of E. coli disease and the join publications between LACER members. In order for the LACER group contributions to be more meaningful, more attention must be paid to the generation and distribution of knowledge and to the attention of the public concerns. Although significant progress continues to be achieved by basic science E. coli researchers, further interactions with policy makers and public health experts' need to be further developed prior to a potential major outbreak, which can guide integration of regional efforts into decision-making processes in how to handle and combat such infections.
